Table 2 Treatment outcomes for participants finishing follow-up as part of therapeutic efficacy monitoring in Angola, 2015
n (%) | ||||||
|---|---|---|---|---|---|---|
Benguela | Zaire | Lunda Sul | ||||
ASAQa | ALa | ALa | DPb | DPb | ASAQa | |
n = 73 | n = 85 | n = 93 | n = 84 | n = 76 | n = 56 | |
Treatment failure | 7 (10) | 9 (11) | 23 (25) | 15 (18) | 0 | 0 |
Early treatment failure | 0 | 1 (1) | 3 (3) | 0 | 0 | 0 |
Late treatment failure | 7 (10) | 8 (9) | 20 (22) | 15 (18) | 0 | 0 |
Recrudescence | 0 | 1 (1) | 8 (9) | 1 (1) | 0 | 0 |
Day 7 | 0 | 0 | 0 | 0 | 0 | 0 |
Day 14 | 0 | 0 | 2 (2) | 0 | 0 | 0 |
Day 21 | 0 | 0 | 6 (6) | 0 | 0 | 0 |
Day 28 | 0 | 1 (1) | 0 | 1 (1) | 0 | 0 |
Day 35 | – | – | – | 0 | 0 | – |
Day 42 | – | – | – | 0 | 0 | – |
Reinfection | 7 (10) | 7 (8) | 12 (13) | 14 (17) | 0 | 0 |
Day 7 | 0 | 0 | 0 | 0 | 0 | 0 |
Day 14 | 0 | 2 (2) | 1 (1) | 0 | 0 | 0 |
Day 21 | 1 (1) | 1 (1) | 6 (6) | 0 | 0 | 0 |
Day 28 | 6 (8) | 1 (1) | 5 (5) | 3 (4) | 0 | 0 |
Day 35 | – | – | – | 5 (6) | 0 | – |
Day 42 | – | – | – | 6 (7) | 0 | – |
Adequate clinical and parasitological response | 66 (90) | 76 (89) | 70 (75) | 69 (82) | 76 (100) | 56 (100) |